This decision support tool has been developed for health workers in the operating theatre environment during the COVID-19 pandemic.
Note: this advice has been updated to reflect the current Delta outbreak in NSW commencing 26 June 2021.
This tool outlines the minimum standards for personal protective equipment (PPE) to be worn by each health worker (HW) in the operating theatre environment. The recommendation for PPE usage needs to be based on:
Within this document, there are three levels of risk identified for operating theatre.
A fourth level (e.g. catastrophic) will be added and implemented should the health system be overwhelmed and/or a state-wide disaster be declared.
These risk levels allow for safe and rational approach to PPE utilisation for the duration of the pandemic. The method for calculating the LHD risk is based on epidemiological parameters and is currently a decision of the NSW Health Risk Escalation Panel. The panel has representatives from PHEOC, Agency for Clinical Information, Clinical Excellence Commission, Ministry of Health, Workforce and HealthShare and meets at least weekly.
The LHD risk rating is determined by the NSW Health Risk and Escalation Panel. If the Panel determines, in collaboration with clinical leaders, that the surgery risk rating should differ from other clinical areas this will be communicated to the system at the same time. LHDs cannot lower their risk rating,but may choose to increase their risk rating based on local context.
NSW Health provides at least weekly updates on it's risk. The overall alert status and the surgery risk level may be different for different geographic areas depending on the location and extent of an outbreak.
The risk of COVID-19 changes over time and is not the same across geographic areas, including local health districts, local government areas or jurisdictions. PHEOC continues to provide advice around
COVID-19 case locations and alerts in NSW.
Aerosol generating procedures(AGPs) are material to the risk posed to the health worker.There are some procedures for which their iis no dispute where there is aerosolisation of respiratory secretions, such as intubation, called high risk in this tool. There are others for which there is some biological plausibility based on evidence from other viral or biological studies (for example colonoscopy). Given COVID-19 is a novel disease and evidence on transmission is continually emerging, recommendations on AGP risks are subject to change. The use of low AGP risk is not standard practice but reflects the need for the staff to be safe where the evidence is incomplete. For the following groups of patients, AGPs should be conducted in a negative pressure theatre if possible:
Information continues to evolve and risk of transmission of COVID-19 can be considered as a combination of intensity, proximity and duration. For example,close contact to a COVID-19 positive patient is at least high risk for transmission irrespective of whether droplets and/or aerosols are produced.
All patients should be screened for risk of COVID-19 and physical distancing should continue where possible, including minimising the number of people in a theatre. Hand hygiene is imperative along with appropriate PPE.
All patients who have suspected or confirmed COVID-19, or who area close contact of someone with COVID-19 (as defined by NSW Health) must be managed with airborne precautions.
Respirators (P2/N95 masks) are part of airborne precautions and are used when performing AGPs. Staff using these devices are expected to have undergone
fit testing and understand and practice fit checking each time they use P2/N95 respirators. See
CEC Respiratory Protection Program for more information.
This document exclusively addresses PPE for the theatre environment. The use of PPE while inside a facility (in particular, masks) must also align with active Public Health Orders.
Definitive and comprehensive advice on PPE utilisation is available in the CEC’s
Infection Prevention and Control Practice Handbookiii, with advice for local health districts to guide responses to changing risk profiles and appropriate infection prevention and control measures in Chapter 3 of the CEC’s
COVID-19-IPAC Manual. All facilities are expected to comply with the infection prevention and control framework including engineering and administrative controls.
An important component of engineering controls is ventilation and airflow within operating theatres. The number of air exchange is an important feature of patient safety to reduce post-operative surgical site infections. Whilst negative air pressure is recommended this may not be achievable.
Note: PPE for transmission-based precautions (contact, droplet or airborne) include all the elements of standard precautions.
As a minimum
In addition to contact precautions
In addition to contact and droplets
Low or High Risk
Non-COVID 19 theatres
High or low risk
High or low risk8
Consider setting up hot and cold zones in Recovery
COVID-19 is a respiratory tract infection predominantly transmitted by large droplets.ii Contact and droplet precautions are therefore recommended during routine care of patients with suspected, probable or confirmed COVID-19.ii,v AGPs may need to be performed during the care of these patients. AGPs may lead to the production of droplet nuclei (<5 micrometres in size) or airborne particles (aerosols) due to air or gas flowing rapidly over a moist or wet surface.vi There are many procedures that may be aerosol generating but evidence is evolving as to whether they lead to an increased risk of respiratory infection transmission.
In addition to the nature of the procedure itself, the overall risk of transmission of SARS-CoV-2 is also associated with the viral load in the body fluid potentially being aerosolised, and whether the virus is intact and capable of causing infection (which is an important distinction, since many body fluid, airsampling and environmental studies use methods that detect any viral RNA rather than intact, infective virus).
Studies have shown that SARS-CoV-2 is most commonly detected in respiratory tract samples (lower greater than upper)in those who are infected; thus procedures involving potential exposure to respiratory tract secretions or tissues are of particular relevance with respect to the risk of COVID-19 transmission.vii SARS-CoV-2 has also been detected in nonrespiratory specimens, in particular stool and to a lesser extent blood and ocular secretions, but the role of these sites in transmission is uncertain. Of note, faecal-oral transmission has not been clinically described, and does not appear to be a significant factor in the spread of infection.xiii
With respect to COVID-19, high risk AGPs are those associated with production of respiratory tract generated aerosols. These procedures have the potential to pose an airborne transmission risk of SARS-CoV-2 and therefore airborne precautions are recommended. High risk AGPs should be performed with the minimum number of personnel present and where possible, the most qualified person should carry out the procedure. In contrast, low risk AGPs for COVID-19 transmission or procedures not associated with the potential to produce aerosols, can be performed using contact and droplet precautions, as indicated for the routine care of suspected, probable or confirmed cases of COVID-19. In general, it is recommended that nebulised medication is avoided in favour of metered dose inhaler and spacer use. If a COVID-19 patient requires an AGP for optimal care, the procedure should be performed with appropriate infection control precautions which will minimise risk to staff.
Table 1 for examples of AGPs of varying risk based on current evidence and expert opinion, including considerations of biological plausibility.ix,
x It must be noted that at present, the evidence is limited and these classifications may change as new data emerge. For guidance regarding other specialised procedures related to allied health interventions, please refer to the CEC website.
Cardiopulmonary resuscitation (CPR) is complex in terms of assessing AGP risk. While many procedures (e.g. intubation), undertaken during the course of CPR, are considered high risk AGPs, it is uncertain whether chest compressions or defibrillation result in aerosol generation or transmission of COVID-19. There is very limited, poor quality data in the current literature concerning this issue.ix,
xi In many reports, it is likely that there was simultaneous exposure to airway manoeuvres, such that the isolated effect of either chest compressions or defibrillation could not be reliably identified. In the setting of low rates of community transmission of COVID-19, chest compression and defibrillation are unlikely to pose a risk to first responders who start CPR, without knowledge of the subject’s COVID-19 status.ii
Healthcare workers can safely start chest compression or defibrillation of a patient with suspected, probable or confirmed COVID-19 using contact and droplet precautions, until another clinician arrives, using airborne precautions, to manage the airway.ii
This document has been developed through review of published literature, clinical guidelines from domestic and international organisations, sourced in April and May 2020, defining suitable personal protective equipment in surgical and procedural care during the COVID-19 pandemic. This published evidence was supplemented with experiential evidence from subject matter experts to specify the protective equipment suitable for various surgical and perioperative care team members.
A sub-committee of the Surgery Community of Practice developed the document, with further input from the broader Surgery Community of Practice and Anaesthesia Community of Practice. This was obtained through virtual consultation with members with expertise in surgical services, anaesthesia, quality and safety, perioperative care, nursing and allied health over a period of four weeks. Further targeted consultation with the Clinical Excellence Commission led to the inclusion of advice relating to aerosol generating procedures. The final document was approved by the Clinical Leads of the Surgery and Anaesthesia Communities of Practice.
This tool has been adapted from:
Surgery community of practice.
Dr Nigel Lyons, Deputy Secretary, Health System Strategy and Planning, NSW Ministry of Health.